Related Experiment Videos

Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients

Patricia Sulzer1,2, Sara Becker1,2, Walter Maetzler2,3

  • 1German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Otfried-Müller-Str. 23, 72076, Tübingen, Germany.

Journal of Neurology
|June 25, 2018
PubMed
Abstract

Insights

A new weighted Montreal Cognitive Assessment (MoCA) score improves the diagnosis of mild cognitive impairment in Parkinson's disease (PD-MCI), particularly in more advanced stages.

Area of Science:

  • Neurology
  • Cognitive Science
  • Biostatistics

Background:

  • Early diagnosis of mild cognitive impairment in Parkinson's disease (PD-MCI) is crucial for predicting Parkinson's disease dementia (PDD).
  • A novel weighting algorithm for the Montreal Cognitive Assessment (MoCA) has shown promise in distinguishing cognitive impairment in PD.
  • Validating this weighted MoCA algorithm in a larger cohort is essential.

Purpose of the Study:

  • To validate a novel weighted scoring algorithm for the MoCA in a large sample of non-demented Parkinson's disease patients.
  • To compare the diagnostic accuracy of the weighted MoCA against the original MoCA for identifying PD-MCI.
  • To hypothesize that the weighted MoCA would demonstrate superior diagnostic accuracy for PD-MCI.

Main Methods:

  • Cognitive status, clinical, and demographic data were collected from 202 non-demented PD patients.
  • The MoCA was administered using both weighted and unweighted scoring methods.
  • Receiver operating characteristic (ROC) curve analysis was employed to assess the discriminative ability of both MoCA versions at different cut-off points (1, 1.5, and 2 SD below norms).

Main Results:

  • Patients with PD-MCI exhibited lower scores on the weighted MoCA compared to the original MoCA (p < 0.001) versus cognitively normal PD patients.
  • Significant differences in discriminative ability were observed at the 2 standard deviation (SD) cut-off.
  • The weighted MoCA demonstrated increased sensitivity (72.9% vs. 70.5%) and specificity (79.0% vs. 65.4%) compared to the original MoCA at the 2 SD cut-off.

Conclusions:

  • The weighted MoCA scoring algorithm shows improved discriminant power for identifying more advanced stages of PD-MCI (2 SD cut-off).
  • These findings suggest the weighted MoCA is a more effective tool for detecting subtle cognitive changes in Parkinson's disease.
  • Further research is warranted to explore the predictive capabilities of the weighted MoCA for the progression to PDD.

Related Concept Videos